NASDAQ:WRND NYLI Global Equity R&D Leaders ETF (WRND) Price, Holdings, & News $42.15 0.00 (0.00%) As of 05/11/2026 02:18 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock About NYLI Global Equity R&D Leaders ETF (NASDAQ:WRND) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get WRND alerts:Sign Up Key Stats Today's Range$42.15▼$42.2550-Day Range$34.51▼$42.3552-Week Range$30.55▼$42.35Volume390 shsAverage Volume840 shsMarket Capitalization$12.65 millionAssets Under Management$10.52 millionDividend Yield1.00%Net Expense Ratio0.18%Aggregate RatingModerate Buy ETF Overview The IQ Global Equity R&D Leaders ETF (WRND) is an exchange-traded fund that is based on the IQ Global Equity R&D Leaders index. The fund tracks an index that seeks to provide exposure to global large- and mid-cap companies that have high research and development spending, and attractive future growth potential. WRND was launched on Feb 8, 2022 and is managed by IndexIQ. Read More NYLI Global Equity R&D Leaders ETF ExpensesTypeWRNDTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.18%0.57%0.57%0.54%0.53%Other Expenses0.02%0.57%0.55%0.51%0.55%Total Expense0.20%0.73%0.76%0.73%0.73%Fee Waiver-0.02%-0.74%-0.64%-0.50%-0.61%Net Expense0.18%0.60%0.63%0.62%0.60% Receive WRND Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NYLI Global Equity R&D Leaders ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WRND ETF News HeadlinesNew York Life Investments Active ETF Trust - Nyli U.s. Large Cap R&d Leaders ETFApril 5, 2026 | fool.comIs NYLI US Large Cap R&D Leaders ETF (LRND) a strong ETF right now?March 25, 2026 | msn.comBSEM: From OTC to Nasdaq Contender!BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited financials for 2024 and 2025 - a key step toward its Nasdaq uplisting. The company paired that move with a $40 million acquisition expanding its reach into hospitals and surgical centers, all within a $300M-plus addressable market. Zacks carries a $25.50 price target on the stock.May 12 at 1:00 AM | Huge Alerts (Ad)Should NYLI US Large Cap R&D Leaders ETF (LRND) be on your investing radar?March 20, 2026 | msn.comSee More Headlines WRND ETF - Frequently Asked Questions How have WRND shares performed this year? NYLI Global Equity R&D Leaders ETF's stock was trading at $37.1950 at the beginning of the year. Since then, WRND stock has increased by 13.3% and is now trading at $42.15. How do I buy shares of NYLI Global Equity R&D Leaders ETF? Shares of WRND stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerNew York Life Investments Fund NameNYLI Global Equity R&D Leaders ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:WRND Inception Date2/8/2022 Fund ManagerGreg Barrato, Francis Ok WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYLI Global Equity R&D Leaders Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings221 Fund Statistics Assets Under Management$10.52 million Average Daily Volume$0.00 Discount/Premium0.07% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorNew York Life Investment Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerGTS Miscellaneous Outstanding Shares300,000Beta1.00 Creation Fee$500.00 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report Top 10 WRND HoldingsNVIDIA (NASDAQ:NVDA)Holding Weight: 8.31%Alphabet (NASDAQ:GOOGL)Holding Weight: 7.27%Microsoft (NASDAQ:MSFT)Holding Weight: 5.59%Taiwan Semiconductor Manufacturing Company LimitedHolding Weight: 5.57%Amazon.com (NASDAQ:AMZN)Holding Weight: 4.97%Apple (NASDAQ:AAPL)Holding Weight: 4.76%Broadcom (NASDAQ:AVGO)Holding Weight: 4.27%ASML Holding N.V.Holding Weight: 3.88%Meta Platforms (NASDAQ:META)Holding Weight: 3.64%AstraZeneca PLCHolding Weight: 2.29%Full Holdings DetailsWRND Sector ExposureWRND Industry Exposure This page (NASDAQ:WRND) was last updated on 5/12/2026 by MarketBeat.com Staff. From Our PartnersNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targe...Equiscreen | SponsoredBSEM: From OTC to Nasdaq Contender!BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...Huge Alerts | SponsoredIf You Have $50k+ on Coinbase, This Will Ruin Your DayIn 2009, Greece's debt-to-GDP ratio hit 130%. Within 24 months... Pensions were slashed 40% overnight. Bank ac...Decentralized Masters | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredRise of the… petroyuan?On February 28th, Iran installed a yuan-denominated toll at the Strait of Hormuz - the chokepoint for one in e...Golden Portfolio | SponsoredNevada gold explorer near Kinross district draws attentionGold has surged past $5,300 per ounce, with Goldman Sachs and JPMorgan forecasting $6,000+ by end of 2026. Cen...Wall Street Logic | SponsoredRead this or regret it foreverThree Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NYLI Global Equity R&D Leaders ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share NYLI Global Equity R&D Leaders ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WRND Stock Alerts